Safety of influenza vaccination: Risk-benefit evaluation.
Wiwanitkit
Viroj
V
D020275:Guillain-Barre Syndrome / Q000209:etiology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D009157:Myasthenia Gravis / Q000276:immunology*
D007252:Influenza Vaccines